The purpose of this study is to determine if recipients of non-myeloablative ex-vivo T-cell
depleted peripheral blood (PBSC) stem cell transplantation using a mismatched related donor
will have less severe graft versus host disease (GVHD), transplant related mortality, and
less graft failure compared to alternative haploidentical stem cell transplantation.